Springer Nature
Clinical Immunotherapeutics Template
Write in a clean editor, then format for Clinical Immunotherapeutics in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Clinical Immunotherapeutics format
Clinical Immunotherapeutics is a peer-reviewed journal published by Springer Nature, covering Asthma and respiratory diseases, Monoclonal and Polyclonal Antibodies Research, Rheumatoid Arthritis Research and Therapies.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Clinical Immunotherapeutics 12, 45–58 (2023).
Formats any DOI in Clinical Immunotherapeutics style. No sign-up. |
| Publishes research in | Asthma and respiratory diseases Monoclonal and Polyclonal Antibodies Research Rheumatoid Arthritis Research and Therapies Immune Cell Function and Interaction Systemic Lupus Erythematosus Research |
| ISSN | 1172-7039 |
| h-index | 20 |
| i10-index | 61 |
| Total citations | 2,073 |
| Top institutions publishing here | University College London |
| Journal website | adisonline.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Clinical Immunotherapeutics per year
Citation impact of Clinical Immunotherapeutics by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Clinical Immunotherapeutics
148 citations
Cite
SaveGo to paper →
144 citations
Cite
SaveGo to paper →
90 citations
Cite
SaveGo to paper →
75 citations
Cite
SaveGo to paper →
51 citations
Cite
SaveGo to paper →
Clinical Immunotherapeutics template — frequently asked questions
How do I write a paper in the Clinical Immunotherapeutics format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Clinical Immunotherapeutics template. When you export, DocuGuru compiles the paper into the official Springer Nature format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Clinical Immunotherapeutics use?
Clinical Immunotherapeutics uses Superscript numbered (Nature) references, shown as superscript numerals in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith, A., Jones, B. & Lee, C. A representative article title. Clinical Immunotherapeutics 12, 45–58 (2023).
Do I need to know LaTeX to submit to Clinical Immunotherapeutics?
No. DocuGuru generates the sn-jnl LaTeX class and compiles the PDF for you in the background, so you get a Springer Nature-ready Clinical Immunotherapeutics document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Clinical Immunotherapeutics template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Clinical Immunotherapeutics format with correct headings, figures, tables, and superscript citations.
Who publishes Clinical Immunotherapeutics?
Clinical Immunotherapeutics is a multidisciplinary journal published by Springer Nature. DocuGuru's Clinical Immunotherapeutics template matches Springer Nature's official submission format.
Can I export a submission-ready Clinical Immunotherapeutics PDF?
Yes — DocuGuru produces a PDF built with the official Clinical Immunotherapeutics template (the sn-jnl class) that is ready to submit to Springer Nature, together with the matching LaTeX source files.
How much does the Clinical Immunotherapeutics template cost?
You can start writing in the Clinical Immunotherapeutics template for free. Exporting the final submission-ready Clinical Immunotherapeutics PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.